HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.

Abstract
Most cancer vaccines induce CTL responses to tumor-associated antigens (TAA). Killing of tumor cells occurs through TAA-specific CTL-mediated cytolysis. Here, we show that one preventive followed by two therapeutic immunizations with an attenuated Listeria monocytogenes (LM)-based vaccine eradicates all metastases and almost the entire primary tumor in the syngeneic, aggressive mouse breast tumor model 4T1. We provide strong evidence that this is due to the combined result of direct kill by Listeria infecting the tumor cells and by CTL responses against Listeria antigens. We showed by electron microscopy that LM expressing truncated listeriolysin O (LLO) and amino acid fragments 311 to 660 of TAA Mage-b (LM-LLO-Mage-b(311-660)) and the control strain LM-LLO infect tumor cells in vitro and in vivo. In vitro data indicate that tumor cell death occurs through activation of NADP(+) oxidase and increased intracellular Ca(2+) levels, both resulting in the production of high ROS levels. Because both LM-LLO and LM-LLO-Mage-b(311-660) showed equally strong efficacies in vivo, we concluded that LM-LLO was crucial and Mage-b was of less importance. We found strong CTL responses to LM-LLO in the spleen, and depletion of CD8 T cells in vivo resulted in significant tumor regrowth (52%) in LM-LLO-vaccinated mice, indicating that LM-LLO-specific CTL indeed partially contributed to tumor cell kill in vivo. This dual mode of action of a Listeria-based vaccine has not been described before and may provide new directions in the development of more effective vaccines against metastatic breast cancer.
AuthorsSun Hee Kim, Francisco Castro, Yvonne Paterson, Claudia Gravekamp
JournalCancer research (Cancer Res) Vol. 69 Issue 14 Pg. 5860-6 (Jul 15 2009) ISSN: 1538-7445 [Electronic] United States
PMID19584282 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Toxins
  • Cancer Vaccines
  • Heat-Shock Proteins
  • Hemolysin Proteins
  • Reactive Oxygen Species
  • Vaccines, Attenuated
  • NADPH Oxidases
  • hlyA protein, Listeria monocytogenes
  • Calcium
Topics
  • Animals
  • Bacterial Toxins (genetics, immunology, metabolism)
  • Breast Neoplasms (parasitology, pathology, ultrastructure)
  • Calcium (metabolism)
  • Cancer Vaccines (administration & dosage, immunology)
  • Cell Line, Tumor
  • Cell Survival
  • Heat-Shock Proteins (genetics, immunology, metabolism)
  • Hemolysin Proteins (genetics, immunology, metabolism)
  • Host-Pathogen Interactions
  • Humans
  • Immunization (methods)
  • Listeria monocytogenes (genetics, immunology, physiology)
  • Mammary Neoplasms, Experimental (immunology, pathology, prevention & control)
  • Mice
  • Microscopy, Electron
  • NADPH Oxidases (metabolism)
  • Neoplasm Metastasis
  • Reactive Oxygen Species (metabolism)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Treatment Outcome
  • Vaccines, Attenuated (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: